- No strong opportunity cluster is confirmed yet; monitor trend and activity pressure.
6657
TAI
Week ended 07 Aug 2026
Weekly Investor Report
Energenesis Biomedical CO.,LTD. · Healthcare · Biotechnology
Latest close
31.20 TWD
3.0%
latest week
Weekly setup
Weak trend
The weekly trend is not active. Price is -23.8% below the Trend Line and sits at 6.5% of its 52-week range. The latest completed week returned 3.0%, after a -11.6% four-week move. Near-term considerations: volume confirmation is below normal.
Setup score
11
out of 100
Latest Close
31.20 TWD
7 Aug 2026
1W Return
3.0%
latest completed week
4W Return
-11.6%
short-term follow-through
12W Return
-20.1%
quarterly tape
Trend Breadth
0.0%
0 of 52 weeks active
Volume Ratio
0.3x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Activity pressure is negative, which weakens the current setup.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
3.0%
Latest completed week; four-week move -11.6%.
Indicator stack
0/19
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Negative 41.82%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is -23.8% below the Trend Line and sits at 6.5% of its 52-week range. The latest completed week returned 3.0%, after a -11.6% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 0.3x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
6 Feb
13 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.0112-week average 0.01
12-week confirmation
Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure0/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.01Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is -11.6% over four weeks, -20.1% over 12 weeks, and -44.8% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year0
Trend breadth0.0%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure-1.54Latest activity-pressure read.
Pressure change-39.2%Four-week change in activity pressure.
Leadership-50.43Latest relative-leadership reading.
RS change-0.3%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment-
No current sentiment snapshot is stored.
Patient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-50.4%Distance below the 52-week high.
13-week volatility5.5%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
6 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher11 of 2615 weeks finished lower.
Best week+10.9%Week of 17 Apr.
Worst week-10.9%Week of 31 Jul.
Latest week+3.0%Week of 7 Aug.
Shape of recent returns
Strong gains3
Modest gains8
Flat weeks0
Modest losses4
Sharp losses11
Recent vol5.5%13-week weekly-return volatility.
Base vol5.0%52-week weekly-return volatility.
Up/down split22/30Count of positive and negative weeks in the 52-week window.
Average skew3.6% / -4.4%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorTW Healthcare
4-week rank47 / 55
Group average-3.9%
Trend breadth30.9%
Trend30.9%active weekly trend signals
MD56.4%positive activity pressure
RS7.3%positive relative leadership
Four-week leaders
IndustryTW Biotechnology
4-week rank15 / 19
Group average-6.3%
Trend breadth31.6%
Trend31.6%active weekly trend signals
MD47.4%positive activity pressure
RS10.5%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape11/100
Trend, activity pressure, participation, and risk combine to a 11/100 tape read.
Indicator analysis9/100Latest 12-week confirmation: trend 0/12, activity pressure 0/12, relative leadership 0/12.
Activity pressure 0.01; No reversal markers Next-Week ExpectancyNegative 41.82%Next-week expectancy is negative with a 41.82% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment50/100No sentiment snapshot is stored yet.
Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 31.20 TWD | 3.0% | 40.92 TWD | 54.43 TWD | -1.54 | -50.43 | 329.1K | Off |
| 31 Jul 2026 | 30.30 TWD | -10.9% | 41.25 TWD | 54.79 TWD | -1.34 | -51.74 | 1.3M | Off |
| 24 Jul 2026 | 34.00 TWD | 0.1% | 41.64 TWD | 55.14 TWD | -1.16 | -47.81 | 745.1K | Off |
| 17 Jul 2026 | 33.95 TWD | -3.8% | 41.94 TWD | 55.39 TWD | -1.10 | -47.96 | 727.6K | Off |
| 10 Jul 2026 | 35.30 TWD | -5.0% | 42.20 TWD | 55.67 TWD | -1.11 | -50.29 | 520.0K | Off |
| 3 Jul 2026 | 37.15 TWD | 6.4% | 42.49 TWD | 55.94 TWD | -1.11 | -50.55 | 528.1K | Off |
| 26 Jun 2026 | 34.90 TWD | -4.6% | 42.77 TWD | 56.10 TWD | -1.01 | -52.54 | 714.6K | Off |
| 19 Jun 2026 | 36.60 TWD | 6.1% | 43.04 TWD | 56.26 TWD | -0.90 | -53.43 | 665.3K | Off |
| 12 Jun 2026 | 34.50 TWD | -10.9% | 43.20 TWD | 56.45 TWD | -0.78 | -54.98 | 2.0M | Off |
| 5 Jun 2026 | 38.70 TWD | 0.3% | 43.49 TWD | 56.65 TWD | -0.76 | -51.72 | 2.7M | Off |
| 29 May 2026 | 38.60 TWD | -4.3% | 43.70 TWD | 56.79 TWD | -0.82 | -52.69 | 1.0M | Off |
| 22 May 2026 | 40.35 TWD | 3.3% | 44.05 TWD | 56.94 TWD | -0.70 | -48.97 | 809.2K | Off |
| 15 May 2026 | 39.05 TWD | -4.8% | 44.39 TWD | 57.10 TWD | -0.57 | -50.55 | 1.2M | Off |
| 8 May 2026 | 41.00 TWD | -2.5% | 44.80 TWD | 57.29 TWD | -0.18 | -49.58 | 1.3M | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.